Answer
Lomitapide mesylate (Lojuxta) is not recommended for children under 18 because its safety and efficacy have not been established and no data are available.
Sources for this answer
- Lojuxta 5mg hard capsulesChiesi Limited · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked